These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 1335650)
41. Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers. Kusov YuYu ; Elbert LB; Nelga IV; Grishina GK; Dunaevski OA; Kharin NV; Maslov YuN ; Drozdov SG; Balayan MS Vaccine; 1991 Aug; 9(8):540-1. PubMed ID: 1663301 [TBL] [Abstract][Full Text] [Related]
42. Safety and immunogenicity of hepatitis A vaccine in healthy children. Horng YC; Chang MH; Lee CY; Safary A; Andre FE; Chen DS Pediatr Infect Dis J; 1993 May; 12(5):359-62. PubMed ID: 8392163 [TBL] [Abstract][Full Text] [Related]
43. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864 [TBL] [Abstract][Full Text] [Related]
44. Safety, tolerability and immunogenicity of a formalin-inactivated hepatitis A vaccine (VAQTA) in rural Kentucky children. Block SL; Hedrick JA; Tyler RD; Smith RA; Calandra G; Patterson C; Lewis J; Sitrin R; Miller W; Schwartz S Pediatr Infect Dis J; 1993 Dec; 12(12):976-80. PubMed ID: 8108223 [TBL] [Abstract][Full Text] [Related]
45. Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection. Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E Vaccine; 1992; 10 Suppl 1():S106-9. PubMed ID: 1335637 [TBL] [Abstract][Full Text] [Related]
46. Brief report: hepatitis A vaccination in Greek military recruits. Papaevangelou G; Totos G; Roumeliotou A; Safary A J Med Virol; 1993 May; 40(1):1-4. PubMed ID: 8390557 [TBL] [Abstract][Full Text] [Related]
47. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437 [TBL] [Abstract][Full Text] [Related]
48. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination]. Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357 [TBL] [Abstract][Full Text] [Related]
49. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine]. Gil A; González A; Dal-Ré ; Aguilar L; Malo C; del Rey J Med Clin (Barc); 1994 May; 102(20):769-71. PubMed ID: 8041214 [TBL] [Abstract][Full Text] [Related]
50. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children. Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652 [TBL] [Abstract][Full Text] [Related]
51. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years. Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885 [TBL] [Abstract][Full Text] [Related]
52. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917 [TBL] [Abstract][Full Text] [Related]
53. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study. Burgess MA; Rodger AJ; Waite SA; Collard F Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336 [TBL] [Abstract][Full Text] [Related]
54. Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. Van Damme P; Matheï C; Thoelen S; Meheus A; Safary A; André FE J Med Virol; 1994 Dec; 44(4):435-41. PubMed ID: 7897376 [TBL] [Abstract][Full Text] [Related]
55. Inactivated hepatitis A vaccine in Chinese patients with chronic hepatitis B infection. Tsang SW; Sung JJ Aliment Pharmacol Ther; 1999 Nov; 13(11):1445-9. PubMed ID: 10571600 [TBL] [Abstract][Full Text] [Related]
56. Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adults. Gil A; González A; Dal-Ré R; Calero JR Vaccine; 1996 Aug; 14(11):1028-30. PubMed ID: 8879097 [TBL] [Abstract][Full Text] [Related]
57. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age. Trofa AF; Klein NP; Paul IM; Michaels MG; Goessler M; Chandrasekaran V; Blatter M Pediatr Infect Dis J; 2011 Sep; 30(9):e164-9. PubMed ID: 21494175 [TBL] [Abstract][Full Text] [Related]
58. [Immunogenicity and efficacy trials of live attenuated hepatitis A vaccines]. Xu Z; Li R; Meng Z Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):254-6. PubMed ID: 10923477 [TBL] [Abstract][Full Text] [Related]
59. The immune response to different doses of inactivated hepatitis A vaccine. Jilg W; Bittner R; Schätzl H; Rasshofer R; Schmidt M; Deinhardt F J Hepatol; 1993; 18 Suppl 2():S38-40. PubMed ID: 8182271 [TBL] [Abstract][Full Text] [Related]
60. A two dose combined hepatitis A and B vaccine in Chinese youngsters. Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]